Correlation Between XSpray Pharma and BioArctic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both XSpray Pharma and BioArctic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XSpray Pharma and BioArctic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XSpray Pharma AB and BioArctic AB, you can compare the effects of market volatilities on XSpray Pharma and BioArctic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XSpray Pharma with a short position of BioArctic. Check out your portfolio center. Please also check ongoing floating volatility patterns of XSpray Pharma and BioArctic.

Diversification Opportunities for XSpray Pharma and BioArctic

XSprayBioArcticDiversified AwayXSprayBioArcticDiversified Away100%
-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between XSpray and BioArctic is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding XSpray Pharma AB and BioArctic AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioArctic AB and XSpray Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XSpray Pharma AB are associated (or correlated) with BioArctic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioArctic AB has no effect on the direction of XSpray Pharma i.e., XSpray Pharma and BioArctic go up and down completely randomly.

Pair Corralation between XSpray Pharma and BioArctic

Assuming the 90 days trading horizon XSpray Pharma is expected to generate 4.55 times less return on investment than BioArctic. In addition to that, XSpray Pharma is 1.04 times more volatile than BioArctic AB. It trades about 0.03 of its total potential returns per unit of risk. BioArctic AB is currently generating about 0.12 per unit of volatility. If you would invest  22,460  in BioArctic AB on November 30, 2024 and sell it today you would earn a total of  2,000  from holding BioArctic AB or generate 8.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

XSpray Pharma AB  vs.  BioArctic AB

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -30-20-10010203040
JavaScript chart by amCharts 3.21.15XSPRAY BIOA-B
       Timeline  
XSpray Pharma AB 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days XSpray Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb30354045
BioArctic AB 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BioArctic AB are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, BioArctic sustained solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb180200220240260280

XSpray Pharma and BioArctic Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-7.35-5.5-3.66-1.810.01.683.45.116.82 0.0170.0180.0190.020
JavaScript chart by amCharts 3.21.15XSPRAY BIOA-B
       Returns  

Pair Trading with XSpray Pharma and BioArctic

The main advantage of trading using opposite XSpray Pharma and BioArctic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XSpray Pharma position performs unexpectedly, BioArctic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioArctic will offset losses from the drop in BioArctic's long position.
The idea behind XSpray Pharma AB and BioArctic AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device